A modular platform leveraging bile salt mechanisms to enhance micronutrient bioavailability, offering compatibility with powders, chews, and encapsulated products. It supports improved solubility and active transport, aiming for commercial integration within 12–18 months.
The modular platform for micronutrient bioavailability is designed to enhance the absorption of challenging nutrients such as fatty acids, amino acids, and peptides. Inspired by the natural function of bile salts, this technology uses safe, food-grade conjugates and coating strategies to improve solubility, protect against degradation, and support active transport across intestinal barriers. This platform is adaptable to various supplement formats, including powders, chews, and encapsulated products, facilitating seamless integration into existing delivery systems. The approach aims to lower required dosages while improving efficacy and tolerability, making it suitable for a wide array of vitamin, mineral, and supplement (VMS) applications.
Key features:
Currently at Technology Readiness Level 3, this platform has undergone early-stage modeling and literature comparison, suggesting strong applicability across multiple nutrient classes. The next steps involve formulation refinement, in vitro testing, and prototype development. With the right partner, the path to commercialization could be achieved within 12–18 months, focusing on generating formulation data, validating delivery performance, and optimizing consumer formats.